{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:05:20Z","timestamp":1767171920377,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In women with unexplained infertility, tubal flushing with oil-based contrast during hysterosalpingography leads to significantly more live births as compared to tubal flushing with water-based contrast during hysterosalpingography. However, it is unknown whether incorporating tubal flushing with oil-based contrast in the initial fertility work-up results to a reduced time to conception leading to live birth when compared to delayed tubal flushing that is performed six months after the initial fertility work-up. We also aim to evaluate the effectiveness of tubal flushing with oil-based contrast during hysterosalpingography versus no tubal flushing in the first six months of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study will be an investigator-initiated, open-label, international, multicenter, randomized controlled trial with a planned economic analysis alongside the study. Infertile women between 18 and 39 years of age, who have an ovulatory cycle, who are at low risk for tubal pathology and have been advised expectant management for at least six months (based on the Hunault prediction score) will be included in this study. Eligible women will be randomly allocated (1:1) to immediate tubal flushing (intervention) versus delayed tubal flushing (control group) by using web-based block randomization stratified per study center. The primary outcome is time to conception leading to live birth with conception within twelve months after randomization. We assess the cumulative conception rate at six and twelve months as two co-primary outcomes. Secondary outcomes include ongoing pregnancy rate, live birth rate, miscarriage rate, ectopic pregnancy rate, number of complications, procedural pain score and cost-effectiveness. To demonstrate or refute a shorter time to pregnancy of three months with a power of 90%, a sample size of 554 women is calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The H2Oil-timing study will provide insight into whether tubal flushing with oil-based contrast during hysterosalpingography should be incorporated in the initial fertility work-up in women with unexplained infertility as a therapeutic procedure. If this multicenter RCT shows that tubal flushing with oil-based contrast incorporated in the initial fertility work-up reduces time to conception and is a cost-effective strategy, the results may lead to adjustments of (inter)national guidelines and change clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>The study was prospectively registered in International Clinical Trials Registry Platform (Main ID: EUCTR2018-004153-24-NL).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02385-1","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:01:29Z","timestamp":1683367289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effectiveness of immediate versus delayed tubal flushing with oil-based contrast in women with unexplained infertility (H2Oil-timing study): study protocol of a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"D.","family":"Kamphuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rosielle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"van Welie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Roest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.C.M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Brinkhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bourdrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mozes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Verhoeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"van der Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. P.J.M.","family":"Vrouenraets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Risseeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Janse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Hundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Huppelschoten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q. D.","family":"Pieterse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Y.","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.M.","family":"Koks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"Lambalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.J.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mijatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"issue":"5","key":"2385_CR1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.fertnstert.2012.11.037","volume":"99","author":"ME Thoma","year":"2013","unstructured":"Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99(5):1324\u201331e1.","journal-title":"Fertil Steril"},{"issue":"1","key":"2385_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.2021.4788","volume":"326","author":"SA Carson","year":"2021","unstructured":"Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65\u201376.","journal-title":"JAMA"},{"issue":"4","key":"2385_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/humupd\/dmh029","volume":"10","author":"JA Collins","year":"2004","unstructured":"Collins JA, Van Steirteghem A. Overall prognosis with current treatment of infertility. Hum Reprod Update. 2004;10(4):309\u201316.","journal-title":"Hum Reprod Update"},{"key":"2385_CR4","unstructured":"NICE. National Institute for Health and Care Excellence (NICE). ; fertility problems: assessment and treatments 2013 [updated 06-07-2017. Available from: https:\/\/www.nice.org.uk\/guidance\/cg156."},{"issue":"2","key":"2385_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.fertnstert.2019.10.014","volume":"113","author":"ASRM","year":"2020","unstructured":"ASRM. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113(2):305\u201322.","journal-title":"Fertil Steril"},{"issue":"3","key":"2385_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0015-0282(16)56578-9","volume":"61","author":"A Watson","year":"1994","unstructured":"Watson A, Vandekerckhove P, Lilford R, Vail A, Brosens I, Hughes E. A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result? Fertil Steril. 1994;61(3):470\u20137.","journal-title":"Fertil Steril"},{"key":"2385_CR7","doi-asserted-by":"crossref","unstructured":"Mohiyiddeen L, Hardiman A, Fitzgerald C, Hughes E, Mol BW, Johnson N et al. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2015(5):CD003718.","DOI":"10.1002\/14651858.CD003718.pub4"},{"key":"2385_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1259\/0007-1285-38-448-301","volume":"38","author":"HW Gillespie","year":"1965","unstructured":"Gillespie HW. The therapeutic aspect of Hysterosalpingography. Br J Radiol. 1965;38:301\u20132.","journal-title":"Br J Radiol"},{"issue":"21","key":"2385_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1612337","volume":"376","author":"K Dreyer","year":"2017","unstructured":"Dreyer K, van Rijswijk J, Mijatovic V, Goddijn M, Verhoeve HR, van Rooij IAJ, et al. Oil-based or Water-Based contrast for Hysterosalpingography in Infertile Women. N Engl J Med. 2017;376(21):2043\u201352.","journal-title":"N Engl J Med"},{"issue":"1","key":"2385_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.fertnstert.2018.03.021","volume":"110","author":"F Fang","year":"2018","unstructured":"Fang F, Bai Y, Zhang Y, Faramand A. Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018;110(1):153\u201360. e3.","journal-title":"Fertil Steril"},{"issue":"2","key":"2385_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/uog.20238","volume":"54","author":"R Wang","year":"2019","unstructured":"Wang R, van Welie N, van Rijswijk J, Johnson NP, Norman RJ, Dreyer K, et al. Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta-analysis. Ultrasound Obstet Gynecol. 2019;54(2):172\u201381.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2385_CR12","first-page":"CD003718","volume":"10","author":"R Wang","year":"2020","unstructured":"Wang R, Watson A, Johnson N, Cheung K, Fitzgerald C, Mol BWJ, et al. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2020;10:CD003718.","journal-title":"Cochrane Database Syst Rev"},{"key":"2385_CR13","unstructured":"NVOG. National Guideline Basic Fertility Work Up. 2015 [Dutch guidelines for Obstetrics and Gynaecology]. Available from: https:\/\/www.nvog.nl\/wp-content\/uploads\/2018\/02\/Ori%C3%ABnterend-Fertiliteitsonderzoek-OFO-3.0-12-11-2015.pdf."},{"issue":"9","key":"2385_CR14","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/humrep\/deh365","volume":"19","author":"CC Hunault","year":"2004","unstructured":"Hunault CC, Habbema JD, Eijkemans MJ, Collins JA, Evers JL, te Velde ER. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod. 2004;19(9):2019\u201326.","journal-title":"Hum Reprod"},{"issue":"3","key":"2385_CR15","first-page":"445","volume":"82","author":"N Moerman","year":"1996","unstructured":"Moerman N, van Dam FS, Muller MJ, Oosting H. The Amsterdam Preoperative anxiety and information scale (APAIS). Anesth Analg. 1996;82(3):445\u201351.","journal-title":"Anesth Analg"},{"key":"2385_CR16","unstructured":"Bouwmans C. Medical Consumption Questionnaire (iMPCQ) 2013 [updated 07-2018. Available from: https:\/\/www.imta.nl\/questionnaires\/."},{"key":"2385_CR17","unstructured":"Bouwmans C. Productivity Cost Questionnaire (iPCQ) 2013 [updated 07-2018. Available from: https:\/\/www.imta.nl\/questionnaires\/."},{"key":"2385_CR18","unstructured":"Nederland Z. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Zorginstituut Nederland; 2016. [."},{"issue":"2","key":"2385_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/0167482X.2010.481337","volume":"31","author":"JR Chachamovich","year":"2010","unstructured":"Chachamovich JR, Chachamovich E, Ezer H, Fleck MP, Knauth D, Passos EP. Investigating quality of life and health-related quality of life in infertility: a systematic review. J Psychosom Obstet Gynaecol. 2010;31(2):101\u201310.","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"6","key":"2385_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/09513590.2018.1540575","volume":"35","author":"C Massarotti","year":"2019","unstructured":"Massarotti C, Gentile G, Ferreccio C, Scaruffi P, Remorgida V, Anserini P. Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. Gynecol Endocrinol. 2019;35(6):485\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2385_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0015-0282(01)02925-9","volume":"77","author":"D Nugent","year":"2002","unstructured":"Nugent D, Watson AJ, Killick SR, Balen AH, Rutherford AJ. A randomized controlled trial of tubal flushing with lipiodol for unexplained infertility. Fertil Steril. 2002;77(1):173\u20135.","journal-title":"Fertil Steril"},{"issue":"9","key":"2385_CR22","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/humrep\/deh418","volume":"19","author":"NP Johnson","year":"2004","unstructured":"Johnson NP, Farquhar CM, Hadden WE, Suckling J, Yu Y, Sadler L. The FLUSH trial\u2013flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: a randomized trial. Hum Reprod. 2004;19(9):2043\u201351.","journal-title":"Hum Reprod"},{"issue":"4","key":"2385_CR23","doi-asserted-by":"publisher","first-page":"hoab033","DOI":"10.1093\/hropen\/hoab033","volume":"2021","author":"JAM Hamilton","year":"2021","unstructured":"Hamilton JAM, van der Steeg JW, Hamilton C, de Bruin JP. A concise infertility work-up results in fewer pregnancies. Hum Reprod Open. 2021;2021(4):hoab033.","journal-title":"Hum Reprod Open"},{"key":"2385_CR24","unstructured":"OECD. Organisation for Economic Co-operation and Development 2021 [Available from: https:\/\/www.oecd.org\/els\/health-systems\/health-data.htm."},{"issue":"4","key":"2385_CR25","doi-asserted-by":"publisher","first-page":"hoac046","DOI":"10.1093\/hropen\/hoac046","volume":"2022","author":"L Shingshetty","year":"2022","unstructured":"Shingshetty L, Maheshwari A, McLernon DJ, Bhattacharya S. Should we adopt a prognosis-based approach to unexplained infertility? Hum Reprod Open. 2022;2022(4):hoac046.","journal-title":"Hum Reprod Open"},{"issue":"6","key":"2385_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.rbmo.2021.03.014","volume":"42","author":"I Roest","year":"2021","unstructured":"Roest I, Rosielle K, van Welie N, Dreyer K, Bongers M, Mijatovic V, et al. Safety of oil-based contrast medium for hysterosalpingography: a systematic review. Reprod Biomed Online. 2021;42(6):1119\u201329.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"2385_CR27","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1007\/s43032-021-00640-0","volume":"28","author":"R Li","year":"2021","unstructured":"Li R, Chen W, Liu Y, Ma L, Qiu L, Han J, et al. The impact of Preconceptional Hysterosalpingography with Oil-based contrast on maternal and neonatal iodine status. Reprod Sci. 2021;28(10):2887\u201394.","journal-title":"Reprod Sci"},{"key":"2385_CR28","doi-asserted-by":"crossref","unstructured":"Mathews DM, Peart JM, Sim RG, Johnson NP, O\u2019Sullivan S, Derraik JGB et al. The SELFI Study: Iodine excess and thyroid dysfunction in women undergoing oil-soluble contrast hysterosalpingography. J Clin Endocrinol Metab. 2022.","DOI":"10.1210\/clinem\/dgac546"},{"issue":"9","key":"2385_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/09513590802246364","volume":"24","author":"K Mekaru","year":"2008","unstructured":"Mekaru K, Kamiyama S, Masamoto H, Sakumoto K, Aoki Y. Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium. Gynecol Endocrinol. 2008;24(9):498\u2013501.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2385_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/humrep\/deaa049","volume":"35","author":"N van Welie","year":"2020","unstructured":"van Welie N, Roest I, Portela M, van Rijswijk J, Koks C, Lambalk CB, et al. Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast. Hum Reprod. 2020;35(5):1159\u201367.","journal-title":"Hum Reprod"},{"key":"2385_CR31","doi-asserted-by":"publisher","first-page":"4532714","DOI":"10.1155\/2022\/4532714","volume":"2022","author":"DM Mathews","year":"2022","unstructured":"Mathews DM, Peart JM, Johnson NP, Sim RG, Heather NL, Webster D, et al. Hysterosalpingography with Oil-Soluble contrast medium does not increase newborn hypothyroidism. Int J Endocrinol. 2022;2022:4532714.","journal-title":"Int J Endocrinol"}],"updated-by":[{"DOI":"10.1186\/s12905-023-02574-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000}}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:05:39Z","timestamp":1700384739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02385-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12905-023-02574-y","URL":"https:\/\/doi.org\/10.1186\/s12905-023-02574-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DK, NvW, IR, AJCMvD, EAB, PB, AM, HRV, DPvdH, FPJMV, JJR, TvdL, JEdH, MdH, AGH, QDP, MYB, and CAMK have nothing to declare. KR and FJ reports receiving a travel grant from Merck. ABH reports receiving a travel \u2013and speaker\u2019s fee from Merck and speakers fee from Nordic Pharma. JS has a research agreement with Takeda not related to this topic. CBL reports receiving research grants from Merck, Ferring and Guerbet. AH reports receiving travel and speaker\u2019s fees from Guerbet and reports past consultancy for Guerbet. WL reports receiving research grants from the NHMRC Centre for Research Excellence in Women\u2019s Health in Reproductive Life and Norman Beischer Medical Research Foundation not related to this study. BWM is supported by a NHMRC investigator grant (GNT1176437) and reports consultancy for ObsEva and Merck and travel support from Merck. KD reports receiving travel and speaker\u2019s fees from Guerbet and research grants from Guerbet. VM reports receiving travel -and speaker\u2019s fees from Guerbet as well as research grants from Guerbet, Merck and Ferring.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is carried out in accordance with the Declaration of Helsinki, the ICH-GCP guidelines and the local regulations. It is approved by the National Central Committee on Research involving Human Subjects (CCMO \u2013 NL 62838.029.18), by the Ethics committee of the Amsterdam UMC, location Vrije Universiteit Amsterdam (Ref. No. 2018.291, date 25th of July 2019) and by the boards of all participating hospitals. The study is also approved by the Research Ethics Committee London Harrow in the UK (Ref. No. 20\/LO\/0608, date 1st of July 2020).The study is registered in International Clinical Trials Registry Platform: EUCTR2018-004153-24-NL.Eligible women will counseled for the study by trained research staff and all women will receive written information. Those women who agree to participate will be asked to sign a written consent form. After informed consent, women will be randomly allocated to the intervention group or control group.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"233"}}